Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02096354 |
|---|---|
| Brief Title: | A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer (ROCKET) |
| First Submitted : | March 20, 2014 |
| First Submitted that Met QC Criteria : | March 21, 2014 |
| First Posted : | March 26, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 12, 2022 |
| Last Update Posted : | May 16, 2022 |